fbpx Skip to main content

You(r) Biocom

When You’re With Biocom – You Are Biocom

Welcome to You(r) Biocom: A Year-Long Campaign Aimed at Showcasing Member-Driven Programs that accelerate life science success.

April Feature: Advocate

Teamwork. Commitment to Service. Passion for the Cause. Innovation. Striving for Excellence. These are the values that drive Biocom every day, in all that we do.

Biocom advocates for all of our members across legislative, business and environmental matters to ensure a future that fosters innovation, informed by the very businesses and organizations shaping the next generation of life science breakthroughs. We are honored to be your leader and advocate during such an exciting time for this industry.   

View past You(r) Biocom posts: December (Impact), November (Recognize), October (Collaborate), September (Educate), August (Innovate), July (Accelerate), June (Showcase), May (Unite),March (Inspire)February (Connect)January (Ignite)

Interested in providing feedback to help us evolve membership benefits even further? Let us know:

About You(r) Biocom 
For nearly 25 years, Biocom members have been instrumental in shaping transformative programming and powerful advocacy that enriches California’s leading life science industry. This year, we’ll be featuring some of our member-driven programs and initiatives that help researchers, investors and advocates alike in our mission to accelerate California’s largest, most innovative network of life science clusters in the world. Stay tuned every month for new ways to take advantage of your Biocom membership benefits.


Keeping a pulse on policies that impact the life science industry

Advocacy at every level

Whether you’re a small, medium, or large-sized company, Biocom’s core advocacy efforts are designed to amplify your company’s influence at the federal, state, and local levels. We educate our policymakers on our industry’s needs, engage them as partners to advance policies that support research and innovation, and actively oppose legislation harmful to life science business.

In Sacramento, Biocom’s voice, often working in concert with our member companies and partner organizations, has led to the changing or shelving of legislation that could adversely affect the industry. In Washington D.C., we advocate before both Congress and federal agencies and leverage our federal group to help define Biocom’s positions and make positive impacts. We also host educational briefings and other events for legislators and their staff throughout the year at all levels of government to educate them on issues important to California’s life science ecosystem.


Your connection to policymakers

In addition to advocating on your behalf, Biocom connects you to policymakers and enables you to be a frontline advocate in Washington, D.C., Sacramento and your local governments.

Members can join our efforts by participating in our annual Advocacy Fly-Ins to Washington, D.C. to meet with regulatory and legislative officials in an intimate setting, monthly regional roundtables featuring facetime with legislators and government agency officials, as well as year-round events and receptions that provide unique opportunities to build your own relationships with legislators, regulators and their staff.


Clearing the runway for innovation

Uniquely California

Biocom’s policy team tracks the unique challenges presented by California’s three major life science clusters: San Diego, Los Angeles and the Bay Area, as well as the state and federal bills that affect them.

This month, some of our policy events include a Bay Area roundtable luncheon with Mayor Arreguín and Mayor Medina of Berkeley and Emeryville, respectively; a community forum with San Diego City Council President Pro Tem Barbara Bry; and a roundtable with the Director of the U.S. Patent and Trademark Office in San Diego. These are but a few of the examples where Biocom affords all members the opportunity to speak directly with leaders and policy makers in an intimate setting.

Biocom’s Own Start-Up Story

Biocom understands the integral role life science startups play in innovating novel solutions that greatly impact the state’s life science success. As many of our members did, Biocom started as a small organization with a simple mission. Our story began in 1995 with the goal of giving San Diego’s life science cluster a unified voice in the county’s water shortage crisis. During a long and severe drought, one of the solutions proposed by the San Diego City Council involved a water-rationing system limiting water distribution to businesses, including local biotech companies.

Industry leaders of the time set out to educate the City Council on the particular needs of life science companies, specifically uninterrupted access to water. Their victory at the City motivated them to formalize the organization that became Biocom. Nearly a quarter of a century later, our commitment to policy that advances the industry is stronger than ever. Biocom’s mission has since grown to support a litany of public policy issues, including state and federal policy matters, business services, workforce trends and empowering California companies whose quest is to improve the lives of many.

Proven results

Biocom has a track record of successes that have benefited members throughout the years. Equipment used in research and development in the life sciences is now exempt from state sales tax due to Biocom efforts, enabling vendors to give our member companies better value. Local zoning changes ensure Biocom service providers and members can operate efficiently and effectively, with minimal impact on and from surrounding commercial and residential neighbors, while Biocom has worked with local government to create award-winning, industry-specific programs to reduce permitting fees and frequency of inspections.

Thanks to the advocacy of Biocom and our partners, funding for the National Institutes of Health (NIH), which benefits research institutes, universities and small companies, has increased by $9 billion in five years, and the medical device tax, which would have cost our medical technology industry $20 billion, has been suspended.

Strength in numbers

Biocom’s public policy initiatives are directly informed by a myriad of member committees. Our committees provide an opportunity for industry professionals to build their network with peers, while also providing them with timely information and best practices in their fields. These committees also yield valuable insight to Biocom staff, determining organizational priorities and positions.

Our Facilities and Environmental Health and Safety Committees in San Diego, Los Angeles and the Bay Area assist in programming workshops and identifying key trends to help members stay abreast of regulatory and policy changes that affect them. Similarly, members of our Intellectual Property Committee receive and discuss updates on court decisions, legislative proposals and regulatory changes that affect patent and IP matters, while those on the Regulatory Affairs Committee exchange best practices and guide the development of Biocom comments on new FDA regulatory guidances. All of these committees also lend their respective expertise to the Legislative and Public Policy Committees, where it informs the development of Biocom positions.